Sandoz Group 

$98.42
357
+$0.00+0%Thursday 21:00

Statistics

Day High
100.5
Day Low
100.5
52W High
100.5
52W Low
66.29
Volume
200
Avg. Volume
88
Mkt Cap
0
P/E Ratio
66.95
Dividend Yield
1.04%
Dividend
1.02

Upcoming

Dividends

1.04%Dividend Yield
Apr 2026
$1.02
Apr 2025
$0.72
May 2024
$0.50
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
41.6%

Earnings

Feb 17Expected
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
Next
1
1.43
1.87
2.3
Expected EPS
2.303373
Actual EPS
N/A

Financials

8.24%Profit Margin
Profitable
2023
2024
2025
11.09BRevenue
914MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SDZXF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap49.72B
Teva Pharmaceutical Industries is a leading global pharmaceutical company that produces generic and specialty medicines, directly competing with Sandoz in the generics market.
Abbvie
ABBV
Mkt Cap514.92B
AbbVie operates in the pharmaceuticals sector focusing on branded drug development, competing with Sandoz's biosimilars and generic pharmaceuticals.
Pfizer
PFE
Mkt Cap167.52B
Pfizer is a research-based biopharmaceutical company that competes with Sandoz in the development and marketing of generic and biosimilar drugs.
Novartis
NVS
Mkt Cap307B
Novartis, the parent company of Sandoz, competes in the pharmaceutical industry but is listed separately due to its broader portfolio of patented drugs, which indirectly competes with Sandoz's generics and biosimilars.
Johnson & Johnson
JNJ
Mkt Cap664.95B
Johnson & Johnson is a comprehensive healthcare company that produces a wide range of pharmaceutical products, competing with Sandoz in various therapeutic areas.
Merck
MRK
Mkt Cap361.73B
Merck & Co. is a global healthcare company that produces prescription medicines, vaccines, biologic therapies, and animal health products, competing with Sandoz in the pharmaceutical sector.
GSK
GSK
Mkt Cap100.88B
GlaxoSmithKline is a global healthcare company that researches and develops a wide range of pharmaceutical products, competing with Sandoz in the generics and biosimilars market.
Sanofi
SNY
Mkt Cap112.71B
Sanofi is a global biopharmaceutical company focused on human health, competing with Sandoz in the areas of generic drugs and biosimilars.
Astrazeneca
AZN
Mkt Cap289.14B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Sandoz in developing and marketing biosimilar products and in the generics field.

About

Sandoz Group AG, headquartered in Rotkreuz, Switzerland, and established in 1886, operates globally in the pharmaceutical sector. The company focuses on the development, production, and commercialization of generic medicines and biosimilars. Beyond this, Sandoz supplies finished dosage forms of small-molecule drugs to third parties. Its portfolio also encompasses protein-based and other biotechnological products, alongside providing biotechnology manufacturing services. A significant aspect of its operations involves anti-infectives, specifically active pharmaceutical ingredients and intermediates, primarily for antibiotics.
Show More
CEO
Richard Saynor
Employees
23000
Country
Switzerland
ISIN
CH1243598427
WKN
000A3ETYB

Listings

0 Comments

Share your thoughts

FAQs

What is Sandoz Group stock price today?▼
The current price of SDZXF is $98.42 USD — it has increased by +0% in the past 24 hours. Watch Sandoz Group stock price performance more closely on the chart.
What is Sandoz Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Sandoz Group stocks are traded under the ticker SDZXF.
Is Sandoz Group stock price growing?▼
SDZXF stock has risen by +0% compared to the previous week, the month change is a +17.12% rise, over the last year Sandoz Group has showed a +48.47% increase.
When is the next Sandoz Group earnings date?▼
Sandoz Group is going to release the next earnings report on February 17, 2027.
What were Sandoz Group earnings last quarter?▼
SDZXF earnings for the last quarter are 1.71 USD per share, whereas the estimation was 1.74 USD resulting in a -1.44% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Sandoz Group revenue for the last year?▼
Sandoz Group revenue for the last year amounts to 11.09B USD.
What is Sandoz Group net income for the last year?▼
SDZXF net income for the last year is 914M USD.
Does Sandoz Group pay dividends?▼
Yes, SDZXF dividends are paid annual. The last dividend per share was 1.02 . As of today, Dividend Yield (FWD)% is 1.04%.
How many employees does Sandoz Group have?▼
As of November 9, 2026, the company has 23,000 employees.
In which sector is Sandoz Group located?▼
Sandoz Group operates in the Health & Wellness sector.
When did Sandoz Group complete a stock split?▼
Sandoz Group has not had any recent stock splits.
Where is Sandoz Group headquartered?▼
Sandoz Group is headquartered in Basel, Switzerland.